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The analysis of the cellular and molecular events that control activation, prolifer- 
ation, differentiation, and tolerance induction in B lymphocytes is currently limited 
by  the  lack  of availability  of homogeneous  populations  of immunocompetent  B 
lymphocytes that can be studied in several phases of their development. Separation 
of B  lymphocytes from  mixed  cell  populations  is  not  a  fully adequate  means  of 
obtaining such ceils.  Available long-term cell lines are also not suitable, since these 
represent  transformed populations  having only limited capacity to respond to im- 
munologic stimuli (1, 2). 
Long-term lines of  cloned, nontransformed B lymphocytes would provide a powerful 
tool for the study of the critical events in B lymphocyte development and function. 
Several groups have succeeded in growing colonies of mouse and human B lympho- 
cytes in soft agar using mitogens, 2-mercaptoethanol, or thymus factors (3-9). How- 
ever, previous efforts to propagate and to clone the progeny of such colonies have not 
been  successful.  In  this  communication, we describe a  technique for the  extended 
culture and cloning of nontransformed human B lymphocytes derived from colonies 
established in soft agar. The requirements for establishing these lines and some of the 
characteristics of these propagated cells are presented. 
Materials and Methods 
Reagents.  Noble  agar and Bacto phytohemagglutinin-M (PHA-M; lot 657315) 1 were ob- 
tained from Difco Laboratories, Detroit, Mich. Purified PHA (lot K7508) was obtained from 
Burroughs Wellcome, Greenville, N. C. Pokeweed mitogen (PWM; lot A393903) was obtained 
from Grand Island  Biological Co., Grand Island; N. Y. Staphylococcus aureus protein A (lot EM 
15140) was obtained from Pharmacia Fine Chemicals,  Div. of Pharmacia, Inc.,  Piscataway, 
N.J. 
Separation of Lymphocytes.  Peripheral blood mononuclear cells were separated from heparin- 
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and are not to be construed as official or reflecting the views of the Department of the Navy or the naval 
service at large. The experiments reported herein were conducted according to the principles set forth in 
the current edition of the Guide for  the Care  and Use of Laboratory  Animals, Institute of Laboratory 
Animal Resources, National Research Council. 
1Abbreviations used in this paper: EBNA, Epstein-Barr nuclear antigen;  FACS, fluorescence-activated cell 
sorter; FCS, fetal calf serum; FI, fluoresceinated; HBSS, Hanks' balanced salt solution; Ig, immunoglobulin; 
IL-2, interleukin 2;  KLH, keyhole limpet hemocyanin; PFC, plaque-forming cell;  PHA, phytohemagglu- 
tinin; PWM, pokeweed mitogen; SRBC, sheep erythrocytes. 
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ized  blood,  obtained  from  normal  volunteers  (Blood  Bank  Department,  Clinical  Center, 
National Institutes of Health), by centrifugation on gradients of Ficoll-Hypaque (Pharmacia 
Fine Chemicals). Cells that banded at the interface were collected, washed in Hanks' balanced 
salt  solution  (HBSS), and resuspended  at  1 ×  10  ° cells/ml  in culture medium. The culture 
medium used for these studies consisted of RPMI 1640 (Grand Island Biological Co.) supple- 
mented with 50 U/ml penicillin,  0.6% L-glutamine,  100/zg/ml gentamyein (Sehering Corp., 
Kenilworth, N.J.), 5 ×  10  -5 M  2-mercaptoethanol, and  10% heat-inactivated fetal calf serum 
(FCS; Microbiological Associates,  Walkersville, Md.). The mononuclear cells were then mixed 
with  neuraminidase-treated  sheep erythrocytes (SRBC)  in a  ratio of 1:40,  in  HBSS supple- 
mented by 25% FCS absorbed with SRBC. Rosettes were formed by incubating this mixture at 
37°C for 15 min, centrifugation at 200 g fr 5 rain, and incubation on ice for 1 h. The SRBC- 
lymphocyte suspension was then layered on Ficoll-Hypaque and centrifuged at 400 g for 20 
mJn at 4°12. The rosetted lymphoeytes in the pellet fraction and unrosetted lymphocytes at the 
interface were removed separately. 
In ~om¢ egpertmcnl;n,  cell  populations were further purified by a  second round of rosette 
folqnatlon accomplished by the ~tddition of a second aliquot of neuraminidase-treated  SRBC, 
t~nd subsequent gentrifuggfion, Rose,ted lymphocytes were suspended in 0.83%  ice-cold am- 
monium ~hloride,0,17 M  Tris  buffer,  pH  7.2,  to  lyse  SRBC.  The  lymphocytes were  then 
centrifuged, washed twice in HBSS, and resuspended  in complete culture medium. We will 
refer to this cell  population as T  lymphocytes, Such populations contained <1% membrane 
lmmunoglobulin (mlg)-bearing cells and < 1% monocytes, as judged by immunofluorescent and 
~terase staining, respectively. 
The cells that failed to form rosettes were subsequently depleted of monorytes by incubation 
at 37°C for 24 h in 150 X  15-mm plastic petri dishes (Falcon Labware, Oxnard, Calif.)  in the 
presence of 20-25 ml complete culture medium. The nonadherent cells will be referred to as B 
lymphocyte-enriched cell  populations. These populations contained  70-83% Ig-positive cells, 
1-4% SRBC rosette-forming cells, and 10-17% monocytes. 
Initial Suspension Culture.  Suspensions of the B lymphocyte-enriched cell  populations  (1  × 
10  n cells/ml) were cultured in complete medium, alone or together with 0.5 X  108 autologous 
T cells that had received 2,500 rod from a cesium irradiator (Gammacell 40, Atomic Energy of 
Canada,  Ltd., Commercial Products, Ottawa, Canada).  PHA-M (12.5/d/ml),  protein A  (10 
/zg/ml), or PWM (2.5/~g/ml) was added and cultures maintained for 72 h at 370C in a water- 
saturated atmosphere of 5-7% CO2 in air.  The cultured cells were then washed, resuspended, 
and needed in the upper layer of a two-layer agar system. 
Colo~ Farrnaliorl #1 8qfl ,~gar.  A  two-layer soft  agar system was prepared  in 30 mm w~lln 
(3~661 Castor, Cambrldp~ Ma~,) aM previously  described (10-12). Briefly, the lower agar layer 
In each wall e0nslnted  ofa ~o~al vnlume of ~.5 ml composed of 1.25 ral of RPM! 1640~ 0,37,5 ml 
of 2x RPMI 1640, 0 5 ml of h0&~,ina~tivawd  gt3S, 0,375 ml of a ~0~k 3,3% a~iar solution, and 
PHA,M (1;!,5/~l/ml),  PWM  (;~,5/~g/ml),  protein A  (10/~j;/ml),  or superr~tp.nt  fa,  ctorn  f'l~m 
human peripheral  blood polls stimulated with PHA or PWM. This layer, which had a  fina) 
agar concentration of 0.5%, was prepared and allowed to equilibrate at 37°C in 5-7% CO2 in 
air for 4-24 h before use. The upper agar layer consisted of a total volume of 0.85 ml composed 
Of 0,3 ml of2x RPM|  1640, 0,15 ml of distilled water, 0.15 ml of FCS, 0.15 ml of a  1.8% agar 
solution, and 0.1 ml of RPMI 1640 containing 1 x  l0  s cells from the initial suspension culture. 
The final agar concentration in the upper layer was 0.32%. The culture dishes were incubated 
at 37"C in a humidified atmosphere containing 5-7% CO2. The development of colonies was 
ob~rved throngh an inverted microscope; the number of colonies was determined  at  4-6 d 
after  seeding  by  counting  colonies  of -50  or  more  cells  from  six  culture  plates  for each 
experiment, 
Pr#paration of Growth Factor-containing Culture Supernates.  The production of growth factor was 
performed a~ described previously (13, 14) with slight modifications. Briefly, growth factor was 
prepared by culturing pooled normal human peripheral blood mononuclear cells at a density 
of 1,5 X  10" cells/ml in RPMI 1640 medium supplemented with 0.3% fresh glutamine,  1 mM 
nonessential ~tmino acids (Microbiological Associates),  5 X  10  -5 M  2-mercaptoethanol, 100 U/ 
ml  p~nicillia~  100/~g/ml  streptomycin,  and  10%  heat-inactivated  FCS.  PHA-P  at  a  fipal 
concentration of ~./~g/ml or PWM at ¢ final concentration of 2.5 #g/ml was added. After 72 h 1502  LONG-TERM  LINES OF  NONTRANSFORMED  HUMAN  B CELLS 
of incubation at 37°C the culture was harvested and the cells removed by centrifugation (2,000 
rpm for  15 min at 4°C). This supernatant preparation, which was designated growth factor- 
containing  culture supernate, was sterilized by filtration through 0.22-p-m filters (Steritol D-GS, 
Millipore Corp., Bedford, Mass.)  and stored at -20°C until used. 
Expansion of CeUsfrom Colonies.  Colonies were picked from soft agar, using a Pasteur pipette, 
under observation with a stereoscopic  microscope.  They were placed in individual wells of 96- 
well round-bottomed microtiter plates (Linbro Scientific, Inc., Hamden, Conn.), together with 
1 ×  104 autologous peripheral blood mononuclear cells, which had received 3,500 rad, or with 
0.05% SRBC as filler cells. Cells were cultured in 100 #1 of RPMI 1640 medium supplemented 
with  growth  factor-containing culture supernate.  The  final concentration of such  culture 
supernate was 40%. After 3-5 d, the cultures were fed with 100p-I  of fresh medium supplemented 
with culture supernate. The cultures were then fed every 3 d by removing 50-70 p-1 of medium 
and replacing it will 100 p-I of medium supplemented with culture supernate. The cultures were 
split as necessary. On occasion, when the cells appeared to be in "crisis," SRBC (0.05%) or 104- 
105 irradiated human peripheral blood mononuclear cells were added to the cultures. 
Detection of Cell-Surface Markers of Cells Harvested  from Colonies.  Colonies formed in soft agar 
were  transferred  with  a  Pasteur  pipette  to  96-well  round-bottomed microtiter  plates  and 
expanded for 3-6 d. These cells were washed twice with RPMI 1640 to remove traces of agar. 
Cells grown from an individual colony were then tested either for their ability to form rosettes 
with SRBC or to ingest latex (15). Progeny of other colonies were tested for mlg by immuno- 
fluorescence.  Fluoresceinated (F1) rabbit anti-human Ig (specific for IgM, IgG, and IgA) and 
Fl-rabbit anti-human IgM (p- chain-specific) were purchased from Cappel Laboratories, Coch- 
ranville, Pa. Fl-rabbit antikeyhole limpet hemocyanin (KLH) was used as a control reagent. 
Limiting  Dilution Cloning.  Cells maintained in long-term culture were cloned by limiting 
dilution (16). Briefly,  cells were  suspended at  densities of 0.3-3/0.2 ml of complete medium 
supplemented with growth factor-containing  culture supernate, at a final concentration of 40%. 
Cell suspensions (0.2 ml) were placed in individual wells of flat-bottomed 96-well  microtiter 
plates.  Irradiated SRBC (0.05 or 0.1%) were added to some of these wells to improve cloning 
efficiency.  2 d  later, the cultures were  fed by adding ~ 100 p.l of medium supplemented with 
growth factor-containing  culture supernate. The medium was changed every 3 d by removing 
most of the medium and replacing it with fresh  medium supplemented with growth  factor- 
containing culture supernates. Wells were  inspected over a period of 10-12 d for cell growth. 
The log of percent of wells in which no growth occurred was plotted against the mean number 
of cells plated per well in order to determine whether likelihood of cell growth conformed to 
predictions of Poisson statistics.  At 14 d, cells from selected  wells with significant growth were 
transferred to larger wells for continued expansion. 
Analysis of mlg Using the Fluorescence-activated Cell Sorter.  Cell surface Ig was examined using 
the fluorescence-activated  cell sorter (FACS II, B-D FACS Systems, Sunnyvale,  Calif.). Aliquots 
of 1 x  105-5 ×  105 cells in 0.2 ml RPMI 1640 containing 5% FCS and 1 mg/ml sodium azide 
were incubated on ice for 30 min with FI-F(ab')2 goat-anti-human  Ig (IgA +  IgG +  IgM) (high 
F/P ratio, Cappel Laboratories)  (1 p-l) or F1-F(ab')2 rabbit-anti-KLH, 4 mg/ml (a gift of Dr. 
Steven Kessler, Uniformed Services University of the Health Sciences, Bethesda, Md.) (0.5 p-l). 
All reagents were centrifuged for 30 min at 107,000 g before use. Staining for human ~ or )k was 
done in a two-step incubation with either a rabbit anti-~ or rabbit anti-X (a gift of Dr. Thomas 
Waldmann, National Cancer Institute), followed by Fl-guinea pig anti-rabbit IgG (a girl of Dr. 
Fred Finkelman, Uniformed Services  University of the Health Sciences).  Cells were washed 
twice before analysis in the FACS. Total scatter and total fluorescence  windows were analzyed 
at appropriate gain settings. 
Assay for Plaque-forming Cells (PFC).  PFC were assayed by the micro-slide modification of 
the Jerne assay  (17). PFC-secreting IgG were  detected by using protein A-coupled SRBC as 
described by Gronowicz et  al.  (18). Cells  were  washed three times and suspended in HBSS 
immediately before assay. Cells (100 p.l) were mixed with 50 p-I of protein A-SRBC and 0.4 ml 
of 0.5% agarose  (Indubiose, Accurate  Chemical  and  Scientific Corp.,  Westbury, N.Y.)  in 
Eagle's minimal essential medium and plated onto microscope slides. After 1 h incubation at 
37°C,  IgG PFC were  developed for  2  h  with a  rabbit anti-human IgG anti-serum (1:200) 
followed  by  1 h with guinea pig complement (1:40)  in Dulbecco's phosphate-buffered saline SREDNI, SIECKMANN, KUMAGAI, HOUSE, GREEN, AND PAUL  1503 
(Grand Island Biological  Co.).  A  rabbit  anti-human  IgD antiserum was used  as  a  control- 
developing reagent. 
Chromosome Analysis.  Chromosome  number  was  determined  essentially  as  described  by 
Ravech~ et al.  (19). Briefly, colehicine,  at a final concentration of 0.05/~g/ml, was added to 1 
×  106 cells. After either a 2-h or an overnight incubation, the cells were centrifuged for 5 min 
at 200 g. The pellet was resuspended in 0.075 M KCI for 30 min, centrifuged for 5 min at 200 
g, and resuspended in 3:1 methanol:acetic acid fixative for 10 rain. The cells were centrifuged 
again,  resuspended in  fixative,  and slides prepared. They were stained  for  15  rain  in  a  4% 
Giemsa solution in Gurr's buffer, pH 6.8. 100 metaphases were analyzed. For analysis of cellular 
DNA content, cells were suspended in HBSS, centrifuged, and stained with propidium iodide 
(5 mg/ml Calbiochem-Behring Corp., San Diego, Calif.)  in 0.1% sodium citrate according to 
the method of Krishan (20). The DNA content of at least 50,000 cells was measured in a Coulter 
TPS-1 cell sorter (Coulter Electronics,  Inc., Hialeah, Fla.). 
Results 
B lymphocyte-enriched cell populations were cultured  for 3 d  with PHA (12.5 #1/ 
ml),  PWM  (2.5  /~g/ml),  or protein  A  (10 ~g/ml).  They were  then  cultured  in  the 
upper  layer of a  two-layer soft  agar culture  system as  described  in  Materials  and 
Methods.  Mitogen  was  included  in  the  lower  agar  layer.  Two  types  of colonies 
developed from these cells. The first, type I, were large colonies of 50-500 cells that 
developed within the upper layer 3-5 d  after seeding. These colonies had a compact 
center and a  diffuse periphery. Colonies of the second type, type II, appeared ~2 d 
later and formed on the surface of the upper agar layer. They were small and flat, 
comprised of 50-150 cells, and usually grew above the primary colonies. Both types 
of colonies began to degenerate on day 7-8 and had completely disintegrated by day 
11. 
The formation of type I colonies depended  upon the presence of mitogen in both 
the initial suspension culture and in the subsequent soft agar culture.  Indeed, if the 
initial  suspension culture was omitted, or if the  mitogenic agent was omitted from 
either culture  step,  the  frequency of colonies was <5%  of the  number that  appear 
when the stimulant was present in both cultures (Table I). Type II colonies occurred 
in higher frequency than type I  colonies, although there was substantial  variability 
among replicate cultures. Although formation of type II colonies had generally similar 
requirements  to  that  for  type  I  colonies,  some  type  II  colonies  formed  from  cell 
populations not subjected to an initial suspension culture. All studies presented in this 
paper on the characteristics and stimulation requirements for colony formation will 
be limited to type I colonies. We do not know whether the cell types present in the 
two types of colonies are similar or different. 
Identification of the Cells Found in Colonies.  Colonies formed as a result of stimulation 
with each of the mitogens were picked from the soft agar on day 4 after seeding and 
transferred  to microtiter wells.  These cells were cultured  in  the presence of growth 
factor-containing culture supernate for 3-6 d. 
Separate groups of 20 colonies were tested for individual characteristics (Table II). 
Surface Ig, as detected by fluorescence microscopy, was found on cells in 90-95% of 
colonies.  More than  80%  of cells in  "positive" colonies were stained  by F1  anti-Ig. 
Approximately 75% of colonies contained IgM-bearing cells. Only 5-10% of colonies 
contained  SRBC  rosette-forming cells and none contained cells that  ingested  latex. 
These results indicate that the great majority of colonies were mainly composed of B 
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TABLE  I 
Induction of Type I Colonies  from B Lymphocyte-enriched Cell Populations 
Initial suspension  Mitogen in soft 
culture*  agar 
Number of colonies/l0  s cells seeded  (± SEM) 
AT$  BK  CD  RB 
Omitted  None  2  (~=1)  1 (-+1)  3  (+-1)  2  (+1) 
Omitted  PHA  6  (---2)  3  (±1)  4  (+2)  7  (-+2) 
No mitogen  PHA  1 (±1)  2  (-+1)  1 (-+1)  3  (±2) 
PHA  None  3  (+1)  2  (:t:1)  4  (±2)  6  (+3) 
PHA  PHA  202  (-+18)  228  (-+19)  270  (±21)  185  (+15) 
Omitted  None  3  (-+1)  5  (±2)  3  (±2)  5  (-+3) 
Omitted  Protein A  18  (±4)  10  (±6)  7  (-+2)  14  (+-7) 
No mitogen  Protein A  1 (-+1)  2  (-+1)  3  (-+2)  1 (-+1) 
Protein A  None  9  (+3)  6  (-+2)  l l  (±5)  5  (:t:3) 
Protein A  Protein A  401  (:1:65)  361  (±42)  245  (+37)  370  (-+51) 
Omitted  None  1 (±1)  5  (+4)  2  (±1)  3  (-+1) 
Omitted  PWM  2  (+l)  4  (+2)  2  (_+1)  3  (-+1) 
No mitogen  PWM  1 (+--1)  1 (-+1)  3  (---2)  2  (-+2) 
PWM  None  1 (±1)  2  (+1)  3  (±1)  3  (+2) 
PWM  PWM  301  (±36)  281  (-+21)  322  (+57)  265  (-+28) 
* Cells were cultured for 3 d in the presence  of no mitogen, PHA (12.5/ll/ml), protein A (10/lg/ml), or 
PWM (2.5/lg/ml). In some instances  the initial suspension  culture was omitted as indicated in the table. 
$ Cells were obtained from four individuals designated AT, BK, CD, and RB. 
TABLE  II 
Characteristics of Mitogen-stimulated Colonies 
Positive colonies/total* 
PHA$  Protein A  PWM 
F 1-anti-lg  18/20  19/20  19/20 
F 1-anti-KLH  0/20  0/20  0/20 
F l-anti-IgM  14/20  14/20  t 6/20 
Rosette formation with SRBC  1/20  2/20  1/20 
Latex ingestion  0/20  0/20  0/20 
* Each reagent was tested  on an independent group of 20 colonies  picked  on day 4 
after seeding in soft agar. 
:[: Mitogen used to initiate colony formation. 
Factors Influencing Development of B  Cell Colonies.  In  most  respects  our  studies  on 
conditions required  for the development of B  cell colonies yielded results very similar 
to those recently reported  by Radnay  et al.  (6)  and  by Muraguchi  et al.  (8)  and  thus 
will  only  be  summarized  here.  We  observed  that  an  initial  suspension  culture  was 
required  to  endow  B  cells  with  colony-forming  capacity  and  that  mitogen  (PHA, 
PWM,  or protein  A)  had  to  be present  during  this suspension  culture.  Furthermore, 
the acquisition  of colony-forming capacity was T  cell dependent.  Rigorous depletion 
of T  cells from the  B  lymphocyte-enriched  cell population  ablated  the ability of the 
B  cells to  develop colony-forming capacity.  Irradiated  T  cells  (10  ~ cells irradiated  at 
2,500  rad)  or growth  factor-containing culture supernate  produced  by PHA  stimula- 
tion  allowed  T  cell-depleted  B  cell  populations  to  acquire  colony-forming capacity 
(Table III). The acquisition of colony-forming capacity during suspension  culture was SREDNI,  SIECKMANN,  KUMAGAI, HOUSE,  GREEN,  AND  PAUL  1505 
TABLE III 
Requirement  for T Lymphocytes or Growth Factors in Initial Suspension 
Cultures 
Colonies/10 s 
Mitogen  Rosetting of  Irradiated T cells*  seeded cells 
lymphocytes  (+ SE) 
PHA  Once~  -  261 (±52) 
Once  +  245 (±61) 
Twice§  -  6 (±2) 
Twice  +  279 (+65) 
Twice  PHA supernatel]  169 (±48) 
PWM  Once  -  84 (± 12) 
Once  +  281  (±76) 
Twice  -  3 (± 1) 
Twice  +  320 (±59) 
Protein A  Once  -  315 (+79) 
Once  +  323 (±92) 
Twice  -  20 (±4) 
Twice  +  285 (±65) 
* T lymphocytes (5 ×  10  s) that received 2,500 rad added to suspension culture. 
:1: B lymphocyte-enriched cell population prepared by one round of rosetting 
contained  70% Ig  + cells and 4% SRBC rosette-forming cells. 
§ B lymphocyte-enriched cell populations prepared by two rounds of rosetting 
contained  79% Ig  + cells and l% SRBC rosette-forming cells. 
]] Irradiated T  cells omitted;  PHA supernate  added to culture medium  at  1 
vol/vol of medium. 
time dependent;  to obtain the maximum number of colonies required  72 h  of initial 
suspension culture. Optimal mitogen doses for acquisition of colony-forming capacity 
were  12.5 #l/ml  for PHA,  2.5/lg/ml  for PWM,  and  10/lg/ml  for protein A. There 
was a  linear relationship between  the number of cells seeded into soft agar and  the 
number of colonies that appeared. 
Mitogen Specificity  of Colony Formation.  B cell colony formation has been reported to 
display  specificity  for  the  mitogenic  agent  used  (8).  We  observed  that  colonies 
appeared  only  when  the  same  mitogenic  agent  was  included  in  both  the  initial 
suspension culture and the subsequent soft agar culture (Table IV). Culture supernates 
of both  PHA-  and  PWM-stimulated  peripheral  blood  mononuclear  cells could  be 
substituted  for  mitogen  in  the  soft  agar  culture.  These  supernates  could  support 
colony formation no matter which of the mitogens were used in the initial suspension 
culture. 
A further demonstration of the mitogen specificity of colony formation was provided 
by experiments in  which  mixtures  of two  mitogens, each  at  optimal concentration, 
were  used  in both  initial suspension cultures and  subsequent  soft  agar culture.  The 
numbers of colonies that formed was greater than that with either mitogen alone and, 
in most cases, was equal to the sum of the number of colonies obtained in response to 
each  mitogen  (Fig.  1).  These  data  suggest  that  B  cells  differ  in  their  capacity  to 
acquire  and  express  colony-forming ability under  the  influence  of these  mitogens. 
However, if the colony-forming unit consists of one (or more) B lymphocyte(s) together 
with a T  lymphocyte, it is possible that the mitogen-specific cell is that T  lymphocyte. 1506  LONG-TERM  LINES  OF  NONTRANSFORMED  HUMAN  B  CELLS 
TABLE IV 
Mitogen Specificity of B Cell Colony Formation 
Stimulant in  Stimulant in agar 
initial 
suspension  --  PHA  PWM  Protein A  PHA  PWM 
culture*  supernate~  supernate~: 
Medium  0  2 (±1)§  1 (+1)  3 (+2)  4 (+2)  6 (±2) 
PHA  6 (+2)  230 (+32)  4 (±2)  6 (±3)  250 (+39)  120 (±17) 
PWM  4 (±1)  3 (±2)  301  (±29)  4 (±1)  175 (±48)  343 (+72) 
Protein A  5 (±2)  4 (±1)  5 (+3)  352  (±27)  212  (±27)  205  (±31) 
*  T  cells (5 X  10S/ml)  that received 2,500 rad were added to B lymphocyte-enriched cells. 
~: Supernate from PHA- or PWM-stimulated peripheral blood mononuclear cells was incorporated in the 
lower agar layer at a final concentration of 25%. 
§ Number (+ SE) of colonies/10  n cells seeded. 
Development of Cell Lines from  Colonies.  Colonies were picked from soft agar at the 
50-150  cell  stage  and  transferred  to  microtiter  wells  for  expansion.  Growth  in 
suspension  culture  was supported with  growth  factor-containing culture  supernate, 
usually used at a final concentration of 40%. "Filler cells" in the form of 104 autologous 
irradiated  peripheral  blood  mononuclear  cells  or  0.05%  SRBC  were  used  at  the 
initiation of the suspension culture. The cultures were then fed every 3 d with growth 
factor-containing culture supernate for several weeks until the cells had increased in 
number to  1 ×  105-2  ×  105. The lines were then transferred to 24-well Costar plates. 
They then entered  a  stationary phase,  referred to as "crisis," which  resembles that 
observed during the expansion of T  cell lines (21). If not further treated, such cultures 
died during the next month. To overcome this, we fed cultured lines that had entered 
crisis with irradiated peripheral blood mononuclear cells on a weekly basis. Depending 
on the number of cells per well, we added  104-105 irradiated cells to each well. During 
this period we continued to feed lines with growth factor-containing culture supernate 
every 3 d. 
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FIG.  1.  Mitogen specificity of colony-forming units. PHA, protein A, and PWM were used alone 
or in mixtures in initial suspension culture and in subsequent soft agar culture. Concentrations of 
mitogens used were:  PHA,  t2.5 #l/ml;  protein  A,  10 ~g/ml;  PWM,  2.5  /~g/ml.  B  lymphocyte- 
enriched cell populations were prepared by one round of rosetting. SREDNI,  SIECKMANN,  KUMAGAI,  HOUSE,  GREEN,  AND  PAUL  1507 
continued to feed with irradiated cells for 2-4 additional wk. The surviving lines were 
then capable of proliferation without further filler cells although continued feeding 
with growth-factor containing culture supernate was essential. 
An example of our success rate in establishing long-term B cell lines is provided by 
the following experiments. 25 colonies were picked from a soft agar plate containing 
PHA in the lower layer. Cells from each of these colonies proliferated in 96-well round 
and then flat-bottomed plates. One line was lost due to contamination. After 6 wk, 
the remaining 24  lines  were  transferred into  24-well Costar plates  and  all  entered 
crisis within 1 wk. During the next 2 wk, 16 of these lines were lost. Of the remaining 
eight, one was lost to contamination and seven survived crisis and were established as 
proliferating lines in the absence of feeder cells.  By fluorescence microscopy, six of the 
seven lines were made up of Ig  + cells and one line was Ig-. Thus, six B cell lines were 
established from an initial group of 25 colonies. 
Lines  that  had  survived  crisis  were  examined  for  proliferation  by  measuring 
thymidine incorporation in the presence and absence of growth factor. As shown in 
Fig.  2,  in  the  presence  of  growth  factor-containing  culture  supernate,  a  linear 
relationship existed between the number of cells cultured and  the amount of [3H]- 
thymidine incorporated during the last 18-24 h ofa 2-d culture period. In the absence 
of growth factor, little, if any, thymidine incorporation was observed. Indeed, B cell 
lines cultured without growth factor-containing culture supernates die in ~48 h. The 
linear relationship between the number of B cells cultured and the magnitude of the 
response suggests that a single cell type was limiting. 
Cell lines have been maintained  in our laboratory for  1 yr or more by repetitive 
feeding and splitting of cultures as necessary.  However, the limiting feature in the 
propagation  of these  cells  is  the  growth  factor.  We  have  observed  considerable 
variability among batches ofcuhure supernates, in both toxicity for cells and capacity 
to support  growth.  In addition, only one of four lots of FCS tested was capable of 
supporting the generation of high levels of growth  factor production by stimulated 
peripheral  blood  mononuclear cells.  It  is  clear that  the  development of a  reliable 
method to produce growth factor, either from normal cells or from tumor cells, would 
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FIG.  2.  Relation  between number of cultured BLI  and BL2 cells and incorporation  of tritiated 
thymidine. BL1 and BL2 are cell lines propagated from a  PHA-stimulated colony and a  protein A- 
stimulated colony, respectively. Cells were cultured for 48 h  and tritiated  thymidine (1 AtCi) was 
present for the last  18 h  of culture. Growth factor was prepared by stimulating human peripheral 
blood mononuclear cells with PHA and was added at a  final concentration of 40%. 
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be  a  major step  toward  making propagation  of cell  lines  a  routine  procedure.  Our 
current procedure for the production of growth factor is to culture 1.5 ×  106 peripheral 
blood  mononuclear  ceils  per  milliliter  from a  pool of normal  donors with  2  ~g/ml 
PHA-P or 2.5/~g/ml of PWM. Supernates harvested from such cultures at  72, 96, or 
120  h  have  substantial  ability  to  support  proliferation  of B  cell  lines.  Supernates 
harvested at 24 h  or 48 h  have much less activity (Fig. 3). 
Cloning from Cell Lines.  As discussed above, the colony-forming unit might poten- 
tially consist of more than  a  single cell.  Consequently, long-term cell lines prepared 
from B lymphocyte colonies may not be the clonal progeny of a single precursor. We 
attempted to prepare cloned lines by limiting dilution culture from one cell line, BL1, 
derived  from a  PHA-stimulated colony. Initially, we tested the capacity of BL1 cells 
plated at 0.3,  1, and 3 cells/well  to grow in the presence of growth factor. We found 
that  very  few  wells  yielded  cell  growth  unless  we  added  SRBC  to  them  at  a 
concentration  of 0.1  or 0.05%.  Both concentrations of filler cells yielded  substantial 
numbers  of wells  with  cell  growth  (Table  V).  We  chose  to  carry  out  subsequent 
limiting dilution cultures using 0.05%  SRBC as fillers because growing lymphocytes 
could be observed in such cultures  without  the need to lyse erythrocytes.  BL1  ceils 
were plated at densities of 0.3, 0.5,  1, 2, and 3/well. Their growth was evaluated over 
a period of 10-12 d. The log of percent of wells in which no cell growth occurred was 
plotted against the mean number of cells plated per well, yielding a straight line that 
intercepted  the  ordinate  at  100%  (Fig.  4).  This  is  consistent  with  growth  being 
dependent  upon  a  single  cell.  Cloning efficiency was  determined  from the  plating 
density which yielded 37% negative wells and was ~36%. 
BLI.1  and  BL1.2  were  lines  propagated  from  these  limiting  dilution  studies,  in 
which BLI.1 was derived from a  well that had received cells at a  density of 0.3/weU 
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FIG. 3.  Capacity of supernate from PHA-stimulated human peripheral blood mononuclear cells 
to support  proliferation of BL1 cells. Human  peripheral  blood mononuclear cells pooled from 
several donors were cultured at 1.5 X 106/ml in the presence of PHA-P (2/.tg/ml). Culture supernates 
were collected at the end of cultures varying from 24 to 120 h. They were added to fresh complete 
medium at a final concentration of 40% and tested for their ability to support tritiated thymidine 
uptake by BL1 cells in 48-h cultures. Tritiated  thymidine (1 /xCi) was added for the last 10 h of 
culture. SREDNI, SIECKMANN, KUMAGAI, HOUSE, GREEN, AND PAUL 
TABLE V 
Growth of Calls Cultured at Limiting Dilution 
Mean number  Number of 
of cells/well  wells 
Number of wells with cell growth* 
No added  0.1%  0.05% 
"fillers"  SRBC  SRBC 
0.3  56  0  7  7 
1  45  0  14  15 
3  39  2  31  29 
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FIe.  4.  Limiting dilution cloning of BL1  cells.  BL1  cells  were distributed  in microtiter wells at 
mean densities varying from 0.3  to 3 cells/well, in the presence of 0.05%  SRBC.  The number of 
wells with cell growth was scored 10-12 d later. The ratio of number of wells with no cell growth to 
total number of wells is shown in parentheses next to each point. The arrows indicate the calculated 
mean number of cells plated per well to yield 37% negative wells. 
and  BL1.2  was  derived  from a  well  that  had  received  cells  at  a  mean  density  of 
1/well. These lines were maintained in the same manner as the parent line. 
Characteristics of Long-term B Cell Lines.  Cells from the BL1, BL1.1, and BL1.2 lines 
were examined for membrane Ig by staining with a Fl-anti-Ig antibodies and analysis 
on the FACS-II. Approximately 90% of BL1 cells were fluorescent after staining with 
a Fl-(Fab')2-anti-Ig antibody; these cells were negative with an Fl-(Fab')2-anti-KLH 
antibody (Fig. 5). BL1.2 cells were stained with anti-K, anti-)`, anti-KLH, or a mixture 
of anti-K and anti-)`, and then counterstained with a  F1 anti-rabbit Ig. The cells were 
negative after staining with anti-KLH. Anti-x and anti-), stained 69.5 and 56.6 of the 
cells, respectively (Fig. 6), and the mixture stained 96.1%. When BL1.1 was examined 
in the same way, 97.1% of the cells were positive with anti-)` and <1% positive with 
anti-x  (Fig.  6). These results indicate that  the long-term lines express membrane Ig 
and  that  BL1  and BL1.2  are almost certainly not  the progeny of single cells, since 
they  contain  both  x-bearing  and  )`-bearing  cells.  By  contrast,  BLI.1  appears  to 
represent  a  cloned line, since all the cells are )`-positive and since, statistically, it is 
quite  unlikely  that  more than  one cell was seeded  into  the well  from which  BLI.1 
grew out. All three lines failed to form rosettes with SRBC and failed to ingest latex 
particles. 
Cells from line SH-1 were tested for Ig production at 5 mo after establishment by 
the protein A  PFC method. The cells, when tested, had been maintained  in several 
different preparations of growth factor. As shown in Table VI, SH-1 cells maintained 
in growth factor preparation 2 (GF-2) contained substantial numbers of IgG-secreting 
cells.  In  contrast,  the  same  line  maintained  in  GF-3  or  GF-4  had  very  few  IgG- 1510  LONG-TERM  LINES OF  NONTRANSFORMED HUMAN B CELLS 
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Fro.  5.  FACS analysis ofmlg-bearing cells from BL1. BLI cells were stained with Fl-(Fab')2-anti- 
Ig or Fl-(Fab')2-anti-KLH and analyzed on the FACS II. Fluorescence intensity is indicated by 
channel numbers on the abscissa, and the number of cells with any given intensity on the ordinate. 
producing cells.  It is interesting that if a  growth factor was removed  1 d  before test, 
the number of IgG-secreting cells  increased substantially, suggesting that as the cells 
cease proliferation, a fraction begin to secrete IgG. The significance of the development 
by anti-8 of 3,000-5,000 protein A PFC/106 cells  in an SH-1 population maintained 
in GF-2 is uncertain. Further studies to clarify this are in progress. 
A  more definitive  demonstration  that  IgG production by cells  of a  single  line  is 
dependent upon the growth factor preparation in which they are maintained is shown 
in Table VII. A group of SH- 1 cells was grown in GF-3 for 1 wk, then transferred to 
GF-4  for another week.  At  this  time,  they were  split  and  grown  for 4  d  in  either 
GF-4 or GF-2. The cells grown in GF-4 contained very few IgG-secreting cells, whereas 
large numbers of IgG-secreting were found in the group grown in GF-2. 
Several  lines  were  examined  for  the  Epstein-Barr  nuclear  antigen  (EBNA)  by 
immunofluorescence. These studies were carried out for us on different samples and 
at  different  times.  We  are  grateful  to  Doctors  Robert  Gallo,  Francis  Ruscetti, 
Giovanna  Tosata,  Michael  Blaese,  and  Ian  Magrath,  all  of the  National  Cancer 
Institute, for performing these tests.  All lines proved to be negative. The lines and the 
times at which they were tested are shown in Table VIII. 
The DNA content of BL1 cells was determined by propridium idodide staining of 
lysed cells  and analysis on a  Coulter TPS-1 cell  sorter.  BL1 cells  had a  modal DNA 
content equivalent to that of normal diploid cells  (Fig.  7). Chromosome number was 
determined on 100 metaphases prepared from BL1. In 93 cases,  46 chromosomes were 
observed.  Of the  remaining  metaphases,  4  had  45  chromosomes, and  metaphases 
containing  59,  65,  and  92  chromosomes were  observed  once  each.  These  results 
indicate that the great majority of BL1 cells  had a normal number of chromosomes. 
Discussion 
The growth of long-term B lymphocyte cell lines and their cloning has the potential 
to provide a powerful tool with which to study the molecular and cellular regulation 
of B  lymphocyte function.  For this purpose,  it  would be desirable  that  the cells  be 
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TABLE  VI 
IgG-secreting Cells in a Long-term B Cell Line * 
Developing  Protein A PFC (PFC/10 s cells) 
reagent 
GF2~.  GF3~.  GF4~ 
+§  -  +  -  +  - 
Anti-'y  22,700  40,710  562  1,803  40  1,300 
Anti-6  5,570  3,290  112  39  13  43 
* Cells from line SH-1 were examined at  ~5 mo after initiation. They were maintained in 
various growth-factor preparations. 
:~ Growth-factor preparation. 
§ +  indicates that  cells were  maintained in growth factor until  time of assay; -  indicates 
that growth factor was removed 18 h before time of assay. 
TABLE  VII 
Capacity of Different Growth Factors to Activate IgG-secreting Cells 
from SH- 1 
Developing reagent  Protein A PFC (PFC/10 s cells) 
GF2 *  GF4 * 
Anti-y  14,420  120 
Anti-~  790  0 
SH-1 cells were cultured for  1 wk in growth-factor preparation 3 and for an 
additional wk in growth-factor preparation 4. They were then split and one 
portion cultured for 4 d  in preparation  2 and a  second portion cultured in 
preparation 4.  Protein A PFC were then measured. 
* Growth-factor preparation. 
TABLE  VIII 
Lack of EBNA in B Lymphocyte 
Time after  Line  EBNA  establishment 
mo 
BL1  4 
BL1  10 
BL1  11 
BL1  12 
BLI.1  7 
BLI.1  8 
BL2  4 
BL2  I0 
BL2  11 
BL2  12 
BL3  4 
BL3  10 
BL3  11 
BL3  12 
















BL1 and SHI are B lymphocyte lines from PHA-stimulated colonies; BLI.I  is 
a  line  from  a  limiting dilution  cloning  (0.3  cells/well)  of BL1;  BL2  is a  B 
lymphocyte line from a  protein A-stimulated colony; BL3 is a  B lymphocyte 









FIc.  7.  Histogram of DNA content of BL1  cells that  had been subjected to hypotonic lysis and 
stained with propidium iodide. The peak channel number for GI cells was the same as that Obtained 
with normal human peripheral blood mononuclear cells stained at the same time. 
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In this paper, we have described an approach through which it has proved possible to 
propagate and clone nontransformed human peripheral blood B lymphocytes. At the 
same  time  these  studies  were  carried  out,  a  somewhat  different  approach  to  the 
propagation of long-term lines of mouse B lymphocytes by Howard et al. (22)  in the 
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, has 
met with success and will be separately reported. 
A key element of the procedure that we have used in the establishment of human 
B lymphocyte lines is the initial stimulation of B lymphocyte-enriched cell populations 
with  mitogenic  agents  followed by colony  formation  in  soft  agar  under  continued 
mitogen stimulation or with the use of a growth factor-containing culture supernate. 
Our results here conform, in general, to those of Radnay et al. (6) and of Muraguchi 
et al.  (8).  The initial  stimulation  appears to be a  T  lymphocyte-dependent process; 
indeed, the mitogenic agents used in the suspension culture are generally considered 
to be T  lymphocyte stimulants. T  lymphocytes can be partially replaced with growth 
factor-containing supernates. Whether the mitogenic agent functions solely to stimu- 
late T  lymphocytes to produce growth factor in situ or, in addition,  interacts with B 
lymphocytes in such a  way as to make them sensitive to growth factor has not been 
determined.  However, the failure of B lymphocytes to grow in soft agar without the 
initial  suspension  culture  step  indicates  that  some  type  of differentiation  event  is 
required  to  endow  the  B  lymphocytes,  or  perhaps  some  postulated  unit  of  a  B 
lymphocyte with another cell type, with colony-forming ability. 
Since T  lymphocyte influences play a critical role in colony formation, it would be 
premature to consider that a colony represented the clonal progeny of a single B cell. 
Indeed,  in  one test of a  long-term B cell line derived  from a  single colony, both r- 
bearing and X-bearing cells were found. This suggests that the original colony must 
have been mixed. Whether this represents a general characteristic of such colonies or 
is a  fortuitous finding has not yet been established. 
We should  note that the B cell lines we have produced  may be generated  from a 
highly selected subset of B cells. First, the frequency of colonies that form in soft agar 
is  generally  of the  order  of 200-400/106  cells  plated,  indicating  that  only  a  small 1514  LONG-TERM LINES  OF  NONTRANSFORMED HUMAN B CELLS 
proportion of the cells plated have the ability to form colonies or are appropriately 
stimulated to do so. Second, of the colonies transferred to suspension culture, only 25- 
35%  survive the period of crisis and  form stable long term lines, again  providing a 
selective step. Thus, any general conclusions drawn from the study of these lines must 
be interpreted with care. 
The growth of cells picked from colonies in soft agar is dependent upon the presence 
of a  growth factor, or perhaps a  collection of growth factors. We have mainly used 
culture supernates from PHA- or PWM-stimulated  human peripheral blood mono- 
nuclear cells.  Such supernates are known  to contain interleukin  2  (IL-2) as well as 
several other lymphoid cell products (23). It has been suggested that IL-2, known to 
support  the  growth  of certain  types of T  lymphocytes  (24),  is  also  critical  to  the 
proliferation of B  lymphocytes. Although we have no decisive evidence concerning 
this, it should be noted that  the time course of production of growth factor in our 
cultures differs from that of IL-2 production. The latter is found quite early in culture 
(25,  26), whereas the development of the human B cell growth factor we have used 
requires  72  h.  Furthermore,  if these  growth  factors  are  involved  in  the  in  vivo 
regulation of lymphocyte growth,  it would seem likely that  separate factors would 
regulate  growth  of  IL-2-dependent  T  cells  and  of  B  cells,  since  immunization 
conditions optimal for one are not usually optimal for the other. Some preparations 
of the growth factor-containing medium also appear to contain the human analogue 
of T cell-replacing factor (27) as the capacity of the cells to differentiate into secreting 
cells depends  on  the growth  factor preparation  in  which  they are  grown.  A  more 
detailed analysis of Ig secretion by these cells is now in progress. 
The B lymphocytes found in the long-term lines and in the clones prepared from 
them do not express EBNA and have a normal number of chromosomes. However, a 
detailed  karyotypic analysis  has  not  yet  been carried out.  Because their growth  is 
dependent  upon  growth  factor, they display  a  retention of certain normal  growth 
regulation properties. Indeed, their ability to secrete Ig is also under factor-dependent 
regulation. These lines promise to provide a  very real resource for the study of the 
activation and regulation of B cell growth and differentiation. 
Summary 
B lymphocyte-enriched cell populations cultured with mitogens in initial suspension 
cultures formed colonies in soft agar when the same mitogenic agent was present in 
the lower layer of a two-layer soft agar system. Colony formation depended upon the 
presence of T  cells in the initial culture, and was optimal after an initial 72-h culture 
with phytohemagglutinin (PHA;  12.5/xl/ml), pokeweed mitogen (PWM; 2.5 #g/ml), 
or protein A  (10 #g/ml). The colonies could be picked from the agar and propagated 
by feeding every 3  d  with  medium  supplemented with  a  growth  factor-containing 
tissue culture supernate.  The growth  factor-containing supernate was  prepared  by 
stimulating pools of human peripheral blood mononuclear cells for 72 h with PHA or 
PWM.  The  lines  propagated  in  this  manner  were  membrane  Ig  +,  lacked  sheep 
erythrocyte rosette-forming ability, and did not ingest latex. They lacked the Epstein- 
Barr  nuclear  antigen  (EBNA)  and  had  46  chromosomes.  Such  lines  have  been 
propagated for over 1 yr. One line (BL1) was subjected to limiting dilution cloning 
and a line, BL1.1, was prepared that contained 96% h-bearing cells and no x-bearing SREDNI,  SIECKMANN, KUMAGAI, HOUSE,  GREEN,  AND PAUL  1515 
cells. This line was also EBNA negative. This procedure can thus be used to prepare 
and clone long-term lines of nontransformed human  B  lymphocytes. 
We  thank  HM2  Emeraldo  B.  Daco  and  Dr.  Irwin  Scher  for  their  assistance  in  the  flow 
microfluorometric studies. 
Received for publication  18 March  1981  and in revised form 17 August  1981. 
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